Bliss GVS Pharma Limited — Important, 30-06-2025: Updates

Bliss GVS Pharma has announced a board meeting to consider the financial results for the quarter and half-year. Separately, the company is initiating the transfer of shares related to unclaimed final dividends from 2017-18 onwards to the Investor Education and Protection Fund (IEPF) Authority, as dividends have remained unpaid for seven years or more. Shareholders are urged to claim dividends or submit required documents to avoid share transfer. No financial impact disclosed from this process.